- Dexcom Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Guidance Dexcom
- DexCom shares tumble 10% despite Q3 earnings beat and raised guidance Investing.com
- DexCom (NASDAQ:DXCM) Given “Hold (C-)” Rating at Weiss Ratings MarketBeat
- Should You Buy DexCom Stock Before Oct. 31? The Motley Fool
- Can Dexcom Deliver Strong Q3 Earnings on Stelo Gains and G7 Adoption? Nasdaq